1
Ship between DC-SCRIPT mRNA levels measured in primary breast cancers and tumor aggressiveness in a much larger, independent, breast cancer cohort. The main clinical endpoints for assessing the prognostic value of DC-SCRIPT expression were disease-free survival (DFS), metastasis-free survival (MFS), and overall survival (OS) in lymph node-negative (LNN) patients who had not received adjuvant syste

Comments

Who Upvoted this Story

What is Plikli?

Plikli is an open source content management system that lets you easily create your own user-powered website.

Latest Comments
Statistics